U.S., Canada, begin trauma experiments

May 27, 2007

The U.S. government is undertaking a set of controversial studies that allows some medical experiments without getting patients' permission.

The $50 million project aims to improve treatment after car accidents, shootings, heart attack and other emergencies, the Washington Post reported Sunday. The five-year project will involve more than 20,000 patients at 11 sites in the United States and Canada.

The experiments aim to find better ways to resuscitate people whose hearts suddenly stop, to stabilize patients in shock and to limit damage from head injuries, the Post reported.

The patients often are unconscious at a time when every minute counts, so it can be impossible to get consent from them or their families, said organizers of the studies. The project is supported by many trauma experts and some bioethicists, while the harshest critics say the experiments violate fundamental ethical principles.

The U.S. National Institutes of Health authorized the study for medical centers doing research in Seattle, Portland, San Diego, Dallas, Birmingham, Pittsburgh, Milwaukee, Toronto and Ottawa, and in Iowa and British Columbia.

Copyright 2007 by United Press International

Explore further: Pharmacists' group discourages providing execution drugs (Update)

Related Stories

Chilly Philae still slumbering, says comet mission

Mar 20, 2015

European space managers Friday ended an eight-day vigil for a wakeup call from the robot lander Philae, but remained hopeful the scout will revive as it rides on a comet nearing the Sun.

Vaccines from a reactor

Mar 02, 2015

In the event of an impending global flu pandemic, vaccine production could quickly reach its limits, as flu vaccines are still largely produced in embryonated chicken eggs. Udo Reichl, Director at the Max ...

New detection technologies for bacterial pathogens

Feb 19, 2015

In FP7 jargon, RAPTADIAG is categorised as a 'small or medium-scale focused research project'. However, the past two years have seen the consortium turn a novel diagnostic test for bacterial meningitis into ...

Recommended for you

Teva buying Auspex for $3.2 billion

Mar 30, 2015

Teva Pharmaceutical Industries Ltd. is buying Auspex Pharmaceuticals Inc. for about $3.2 billion in a move to strengthen its position on central nervous system condition treatments.

Oral hepatitis B vaccine could become a reality

Mar 30, 2015

In a new study, researchers report progress toward perfecting a radical new method of producing vaccines using genetically modified corn. The approach could lead to an oral hepatitis B vaccine that requires no refrigeration ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.